clinical trial · NCT06443489
A Trial of SHR-4849 in Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.·phase1·recruiting·n = 80
Advanced Solid TumorsSHR-4849
brief summary
The study is being conducted to evaluate the safety, tolerability and efficacy of SHR-4849 injection in Advanced Solid Tumors. To explore the reasonable dosage of SHR-4849 for Advanced Solid Tumors.
started
Jun 26, 2024
primary completion
Dec 1, 2026
completion
Dec 1, 2026
last updated
Mar 5, 2025
official title
A Phase I ,Open-label, Multicenter Clinical Study to Evaluate the Safety, Tolerability , Pharmacokinetics and Efficacy of SHR-4849 in Patients With Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol